enfortumab vedotin (EV) Clinical Trials

3 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Pipeline

Phase 1: 1Phase 2: 1Phase 2/3: 1

Top Sponsors

Summit Therapeutics1
Peking University Third Hospital1
Generate Biomedicines1

Indications

Cancer3
Metastatic Urothelial Carcinoma2
Metastatic Urothelial Carcinoma (UC)1
Advanced Urothelial Cancer1
Muscle Invasive Bladder Cancer (MIBC)1

Other1 trial

EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC

Phase 2

Phoenix, Arizona1 trial

A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma

Research Site

Phase 2/3

Duarte, California1 trial

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

City of Hope

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.